Association of AXIN2 and MMP7 polymorphisms with non-small cell lung cancer in Chinese Han population

International Journal of Clinical and Experimental Pathology

Volumn 9, Issue 2, 2016, Pages 2253-2258

  Han, Shuguang ^a   Lv, Lei ^a   Wang, Xinhua ^a   Wang, Xun ^a   Zhao, Hongqing ^a  

^a WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

AXIN2; MMP7; Non small cell lung cancer; Polymorphism

Indexed keywords

EID: 84966781432     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90
2. Collins LG, Haines C, Perkel R and Enck RE. Lung cancer: diagnosis and management. Am Fam Physician 2007; 75: 56-63
3. Herbst RS, Heymach JV and Lippman SM. Lung cancer. N Engl J Med 2008; 359: 1367-80
4. Prabhakar CN. Epidermal growth factor receptor in non-small cell lung cancer. Transl Lung Cancer Res 2015; 4: 110-8
5. Dong H, Bao D, Guo X, Hu J, Li X, Wan S and Xing J. Effect of thymidylate synthase gene polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer patients. Tumour Biol 2015; [Epub ahead of print]
6. Rafrafi A, Kaabachi S, Kaabachi W, Chahed B, Amor AB, Mbarik M, Charrad R, Salah MO, Hamzaoui K and Sassi FH. CCR2-64I polymorphism is associated with Non-Small Cell Lung Cancer in Tunisian patients. Hum Immunol 2015; 76: 348-354
7. Gu AQ, Wang WM, Chen WY, Shi CL, Lu JH and Han JQ. XRCC1 genetic polymorphisms and sensitivity to platinum-based drugs in non-small cell lung cancer: an update meta-analysis based on 4708 subjects. Int J Clin Exp Med 2015; 8: 145-154
8. Piven OO, Pal'chevs'ka OL and Lukash LL. [The Wnt/beta-catenin signaling in embryonic cardiogenesis, postnatal development and myocardium reconstruction]. Tsitol Genet 2014; 48: 72-83
9. Yuan G, Yang G, Zheng Y, Zhu X, Chen Z, Zhang Z and Chen Y. The non-canonical BMP and Wnt/beta-catenin signaling pathways orchestrate early tooth development. Development 2015; 142: 128-139
10. Zhang K, Zhu S, Liu Y, Dong X, Shi Z, Zhang A, Liu C, Chen L, Wei J, Pu P, Zhang J, Jiang T, Han L and Kang C. ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/beta-catenin activity. Cancer Lett 2015; 357: 404-411
11. Chen X, Song X, Yue W, Chen D, Yu J, Yao Z and Zhang L. Fibulin-5 inhibits Wnt/beta-catenin signaling in lung cancer. Oncotarget 2015; 6: 15022-34
12. Mai M, Qian C, Yokomizo A, Smith DI and Liu W. Cloning of the human homolog of conductin (AXIN2), a gene mapping to chromosome 17q-23-q24. Genomics 1999; 55: 341-344
13. Ma C, Liu C, Huang P, Kaku H, Chen J, Guo K, Ueki H, Sakai A, Nasu Y, Kumon H, Shimizu K and Watanabe M. Significant association between the Axin2 rs2240308 single nucleotide polymorphism and the incidence of prostate cancer. Oncol Lett 2014; 8: 789-794
14. Muto Y, Maeda T, Suzuki K, Kato T, Watanabe F, Kamiyama H, Saito M, Koizumi K, Miyaki Y, Konishi F, Alonso S, Perucho M and Rikiyama T. DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability. BMC Cancer 2014; 14: 466
15. Gunes EG, Pinarbasi E, Pinarbasi H and Silig Y. Strong association between lung cancer and the AXIN2 polymorphism. Mol Med Rep 2009; 2: 1029-1035
16. Knox JD, Boreham DR, Walker JA, Morrison DP, Matrisian LM, Nagle RB and Bowden GT. Mapping of the metalloproteinase gene matrilysin (MMP7) to human chromosome 11q21→q22. Cytogenet Cell Genet 1996; 72: 179-182
17. Nakamura M, Miyamoto S, Maeda H, Ishii G, Hasebe T, Chiba T, Asaka M and Ochiai A. Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability. Biochem Biophys Res Commun 2005; 333: 1011-1016
18. Jiang Y, Sun S, Liu G, Yan B and Niu J. Nrdp1 inhibits metastasis of colorectal cancer cells by EGFR signaling-dependent MMP7 modulation. Tumour Biol 2015; 36: 1129-1133
19. Kwon M, Lee SJ, Wang Y, Rybak Y, Luna A, Reddy S, Adem A, Beaty BT, Condeelis JS and Libutti SK. Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis. Int J Cancer 2014; 135: 48-60
20. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469-480
21. Cadigan KM and Liu YI. Wnt signaling: complexity at the surface. J Cell Sci 2006; 119: 395-402
22. Logan CY and Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20: 781-810
23. Zhang Y, Zhang X, Huang J and Dong Q. Wnt signaling regulation of stem-like properties in human lung adenocarcinoma cell lines. Med Oncol 2015; 32: 157
24. Li C, Song G, Zhang S, Wang E and Cui Z. Wnt3a increases the metastatic potential of non-small cell lung cancer cells in vitro in part via its upregulation of Notch3. Oncol Rep 2015; 33: 1207-1214
25. Coscio A, Chang DW, Roth JA, Ye Y, Gu J, Yang P and Wu X. Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients. Carcinogenesis 2014; 35: 1284-1291
26. Haramis AP, Hurlstone A, van der Velden Y, Begthel H, van den Born M, Offerhaus GJ and Clevers HC. Adenomatous polyposis coli-deficient zebrafish are susceptible to digestive tract neoplasia. EMBO Rep 2006; 7: 444-449.